CO.’S PROTEIN ENGINEERING COULD TREAT MORE THAN JUST CANCER
French Pharma Company to Pay $2.5 Billion for Synthorx
Sunday, December 15, 2019
Laura Shawver, CEO of Synthorx, in the lab located in the incubator COI Pharmaceuticals. Synthorx was recently acquired in a $2.5 billion deal. Photo by Jamie Scott Lytle.
French pharmaceutical Sanofi will pay $2...
Take 1 minute to subscribe and you'll get this story immediately, plus:
Already a subscriber? Sign in
- 52 weekly issues
- Subscriber-only digital content every business day, plus full access to SDBJ.com archives
- Book of Lists — the most comprehensive business resource in San Diego
- San Diego 500 — influential business leaders you need to know